| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/21/2012 | US20120156239 Optimized vaccines to provide protection against ebola and other viruses |
| 06/21/2012 | US20120156238 Herpes virus backbone for viral vaccine and vaccine based thereon |
| 06/21/2012 | US20120156215 Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications |
| 06/21/2012 | US20120156174 Novel bacteriophage and antibacterial composition comprising the same |
| 06/21/2012 | DE102010054766A1 Verfahren zur Trennung, Aufkonzentration oder Reinigung eines (Blut)Plasmaproteins oder Virenbestandteils aus einer Mischung Process for the separation, concentration or purification of a (blood) plasma protein or virus component of a mixture |
| 06/21/2012 | CA2821289A1 Adenovirus serotype 26 and serotype 35 filovirus vaccines |
| 06/20/2012 | EP2465927A1 Influenza hemagglutinin and neuraminidase variants |
| 06/20/2012 | EP2465926A1 Pseudomonas aeruginosa Bacteriophage and uses thereof |
| 06/20/2012 | EP2465531A1 Apoptosis-inducing polypeptides |
| 06/20/2012 | EP2181189B1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
| 06/20/2012 | CN102505022A RNA interference vector capable of simultaneously silencing multiple ligands of NKG2D, and construction method and application thereof |
| 06/20/2012 | CN102504014A Peptidomimetic protease inhibitors |
| 06/20/2012 | CN101942425B Enzyme related to benzalacetone synthesis, coding gene and application thereof |
| 06/20/2012 | CN101850115B Method for producing swine fever live vaccine by using porcine kidney cell line (IBRS-2) and product thereof |
| 06/20/2012 | CN101798568B Separated vibrio parahaemolyticus phage and applications in sterilization and microbe-proofing thereof |
| 06/20/2012 | CN101768576B HSV1-TK (herpes simplex virus type 1-thymidine kinase) gene recombination oncolytic adenovirus, preparation method and application thereof |
| 06/20/2012 | CN101163510B Virus inactivation method, processing system and device used therein |
| 06/19/2012 | US8202717 Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus |
| 06/19/2012 | US8202521 Methods and compositions for poxvirus lacking A35R protein |
| 06/14/2012 | WO2012078069A1 Spherical nano- and microparticles derived from plant viruses for the display of foreign proteins or epitopes |
| 06/14/2012 | US20120151614 Vector utilizing borna disease virus and use thereof |
| 06/14/2012 | US20120149010 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
| 06/14/2012 | US20120148624 Mutants of cholesterol-dependent cytolysins and uses thereof |
| 06/14/2012 | US20120148622 Live Attenuated Influenza Virus Vaccines Comprising Microrna Response Elements |
| 06/14/2012 | US20120148535 Oncolytic adenoviruses for treating cancer |
| 06/14/2012 | US20120148505 Reduction In Bacterial Colonization By Administering Bacteriophage Compositions |
| 06/13/2012 | EP2463362A1 Simian subfamily c adenovirus SAdv-31 and uses thereof |
| 06/13/2012 | EP1828390B1 Chimeric vectors |
| 06/13/2012 | EP1663302B1 Method for vaccination of poultry by bacteriophage lysate |
| 06/13/2012 | EP1516058B1 Recombinant measles viruses expressing epitopes of antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 06/13/2012 | EP1458856B1 Isolated phages and their use in food or pet food products |
| 06/13/2012 | EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins |
| 06/13/2012 | EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same |
| 06/13/2012 | EP0451216B2 Humanized immunoglobulins and their production and use |
| 06/13/2012 | CN102492662A Method for marking live viral particles in multicolor |
| 06/13/2012 | CN102492661A Preparation method and application of immunization preparation for controlling novel duck reovirus |
| 06/13/2012 | CN102492660A Hepatitis B virus mutant, mutation amplification kit and application thereof |
| 06/13/2012 | CN102492659A Production method for hepatitis A virus for vaccine production |
| 06/13/2012 | CN102488893A Duck hemorrhagic oophoritis inactivated vaccine production method by using cell line and product thereof |
| 06/13/2012 | CN102146130B Plant stress tolerance associated protein SeVP2 as well as coding gene and application thereof |
| 06/13/2012 | CN102146129B Protein SeVP1 related to stress tolerance of plants and encoding gene and application thereof |
| 06/13/2012 | CN101343315B Shorten human papilloma virus 6 type L1 protein |
| 06/13/2012 | CN101307085B SiRNA and recombination lentivirus from preventing hepcidin from regulating protein and uses thereof |
| 06/12/2012 | US8198426 Nucleic acid containing one or more adaptive mutations, and Hepatitis c Virus (HCV) replicon enhanced cells ( cells having an increased ability to maintain an HCV replicon) |
| 06/12/2012 | US8198234 Methods of suppressing microglial activation |
| 06/12/2012 | US8198084 Serum-free mammalian cell culture medium, and uses thereof |
| 06/12/2012 | US8198031 Detecting and profiling molecular complexes |
| 06/12/2012 | US8197825 Recombinant MVA virus and the use thereof |
| 06/12/2012 | US8197824 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 06/12/2012 | CA2495294C Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 06/12/2012 | CA2463090C Recombinant rabies vaccine and methods of preparation and use |
| 06/12/2012 | CA2270178C Viral variants and methods for detecting same |
| 06/07/2012 | WO2012022496A3 Method for killing tumor stem cells |
| 06/07/2012 | US20120142764 Multi-Cistronic shRNA Expression Cassette for Suppressing Single or Multiple Target Genes |
| 06/07/2012 | US20120142078 System for generation of viable reovirus from cloned cdna |
| 06/07/2012 | US20120141980 Method for isolating viruses |
| 06/07/2012 | US20120141977 Hepatitis b virus mutation strain with resistance to adefovir dipivoxil and the uses thereof |
| 06/07/2012 | US20120141590 Technology for the Preparation of Microparticles |
| 06/07/2012 | US20120141525 Universal influenza vaccine based on recombinant modified vaccine ankara virus (mva) |
| 06/07/2012 | US20120141453 Glycosidase Enzymes |
| 06/07/2012 | US20120141427 Attenuated Strain of Myxoma Virus for Use as an Oncolytic Drug |
| 06/07/2012 | US20120141426 Reovirus for the Treatment of Cellular Proliferative Disorders |
| 06/07/2012 | US20120141418 Treatment of Melanoma Using HSV Mutant |
| 06/06/2012 | EP2460878A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 06/06/2012 | EP2460822A2 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 06/06/2012 | EP2460821A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460820A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460819A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460818A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460817A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460816A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2459722A1 Reverse genetics systems |
| 06/06/2012 | EP2459709A2 High yield yellow fever virus strain with increased propagation in cells |
| 06/06/2012 | EP2459585A1 Influenza viruses and uses thereof |
| 06/06/2012 | EP2128261B1 A recombinant adenovirus comprising recombinant khp53 gene and preparation method and uses thereof |
| 06/06/2012 | CN101979513B Duck-origin paramyxovirus attenuated lapinized Chineses (LC) strain and application thereof to the preparation of vaccines |
| 06/06/2012 | CN101935675B Construction and application of cell membrane expression ALV-env fluorescin eukaryotic transgenic expression plasmid |
| 06/05/2012 | US8192975 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 06/05/2012 | US8192747 Comprising a rotavirus antigen, a sugar and a carboxylate, between pH 5.0 and pH 8.0 and no phosphate or less than 5 mM phosphate; for human infants |
| 06/05/2012 | CA2403701C Recombinant parainfluenza virus expression systems and vaccines |
| 06/05/2012 | CA2292882C Mutant having uracil phosphoribosyl transferase activity |
| 05/31/2012 | WO2012071276A1 Oncolytic virus as an inducer for innate antitumor immunity |
| 05/31/2012 | WO2012070639A1 Neuron-specific retrograde transport vector |
| 05/31/2012 | WO2012069190A2 Depletion of host cell components from live vector vaccines |
| 05/31/2012 | WO2012021783A3 Dry storage stabilizing composition for biological materials |
| 05/31/2012 | WO2011157447A3 Modified parvovirus having enhanced anti-tumour efficacy |
| 05/31/2012 | WO2011154976A3 Improved influenza vaccine |
| 05/31/2012 | WO2011146933A3 Universal dengue virus sequences and methods of use |
| 05/31/2012 | US20120137379 Novel aav's and uses thereof |
| 05/31/2012 | US20120135999 Compounds and methods for antiviral treatment |
| 05/31/2012 | US20120135954 Compounds for preventing or treating viral infections and methods of use thereof |
| 05/31/2012 | US20120135515 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 05/31/2012 | US20120135501 Recombinant poxvirus expressing homologous genes inserted |
| 05/31/2012 | US20120135023 Influenza hemagglutinin and neuraminidase variants |
| 05/31/2012 | US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3 |
| 05/31/2012 | US20120135017 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| 05/31/2012 | US20120134963 Compositions and methods for enhancing virus efficacy |
| 05/31/2012 | US20120134957 Latent phase viral interleukin-10-(vii-10) and uses thereof |
| 05/30/2012 | EP2458003A1 Attenuated chimeric flavivirus bearing attenuated jamanese encephalitis virus gene as backbone |
| 05/30/2012 | EP2456855A2 Drain down and re-feed of microcarrier bioreactor |